CoChat
Sign Up
Cited by 42Consumer Attitudes and Food LabelingFood and Agricultural SciencesAgricultural safety and regulations

Functional Foods in Europe: A Focus on Health Claims

Open access
Pravst, Igor·2012·Scientific, Health and Social Aspects of the Food Industry
DOI 10.5772/31057
Open this paper in CoChat — free accountOpen PDF

Abstract

amounts, although some functional foods can be intended for specific populations.This is contrary to medicine, which is intended for curing a disease or treating its symptoms, and used in exactly defined quantities to minimize side effects and assure therapeutic action.Food legislation also defines food supplements and foods for special medical purposes.Food supplements are concentrated sources of nutrients or other substances with a nutritional or physiological effect and are meant for supplementing a normal diet.Supplements are usually marketed as capsules, pastilles, tablets, pills and other similar forms of liquids and powders designed to be taken in measured small unit quantities.In contrast, foods for special medical purposes are specifically formulated, processed and intended for the dietary management of diseases, disorders or medical conditions of individuals who are being treated under medical supervision.These foods are intended for the exclusive or partial feeding of people whose nutritional requirements cannot be met by normal foods. Functional food Medicinal food Medicine UsageProviding nutritional needs, weight management, supporting health of digestive system, skeleton, heart, reducing risk of development of certain diseases. How to referenceIn order to correctly reference this scholarly work, feel free to copy and paste the following:Igor Pravst (2012).Functional Foods in Europe: A Focus on Health Claims, Scientific, Health and Social Aspects of the Food Industry, Dr. Benjamin Valdez (Ed.),

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5772/31057

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Scientific opinion was provided for 2,758 general function health claims, with about 20% being approved.

    “Scientific opinion was provided for 2,758 general function health claims, with about 20% being approved (Pravst, 2012;Verhagen & van Loveren, 2016;Verhagen, Vos, Francl, Heinonen, & van Loveren, 2010).”

    From Comparison of requirements for using health claims on foods in the European Union, the USA, Canada, and Australia/New Zealand (2021) · cites this paper as Pravst, 2012

    Section 5, “Evaluation and authorisation of health claims,” says scientific advice was provided for 2,758 general function health claims and about 20% received favourable opinions. It distinguishes EFSA’s scientific assessment from authorisation by the European Commission, so “approved” overstates what the 20% figure establishes. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 141

  1. Arvanitoyannis, I.S. & Houwelingen-Koukaliaroglou, M. (2005). Functional foods: A survey of health claims, pros and cons, and current legislation. Crit. Rev. Food Sci. Nutr. 45(5): 385-404.
  2. Bitzios, M., Fraser, I. & Haddock-Fraser, J. (2011). Functional ingredients and food choice: Results from a dual-mode study employing means-end-chain analysis and a choice experiment. Food Policy. 36(5): 715-725.
  3. Bonsmann, S.S.G., Celemin, L.F., Larranaga, A., Egger, S., Wills, J.M. et al. (2010). Penetration of nutrition information on food labels across the EU-27 plus Turkey. European Journal of Clinical Nutrition. 64(12): 1379-1385.
  4. Burton, R.A. & Fincher, G.B. (2009). (1,3;1,4)-beta-D-Glucans in Cell Walls of the Poaceae, Lower Plants, and Fungi: A Tale of Two Linkages. Molecular Plant. 2(5): 873-882.
  5. Cappuccio, F.P. & Pravst, I. (2011). Health claims on foods: Promoting healthy food choices or high salt intake? British Journal of Nutrition. In press (doi:10.1017/S0007114511002856) · DOI · Paper page
  6. Cazaubiel, M. & Bard, J.M. (2008). Use of biomarkers for the optimization of clinical trials in nutrition. Agro Food Industry Hi-Tech. 19(5): 22-24.
  7. Celemin, L.F., Bonsmann, S.S.G., Carlsson, E., Larranaga, A. & Egger, S. (2011). Mapping public health nutrition awareness campaigns across Europe. Agro Food Industry Hi- Tech. 22(1): 38-40.
  8. Colombo, M.L. (2010). Conventional and new foods: health and nutritional claims The new functional role of food. Agro Food Industry Hi-Tech. 21(1): 42-44.
  9. Covas, M.I., de la Torre, K., Farre-Albaladejo, M., Kaikkonen, J., Fito, M. et al. (2006a). Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radical Biology and Medicine. 40(4): 608-616.
  10. Covas, M.I., Nyyssonen, K., Poulsen, H.E., Kaikkonen, J., Zunft, H.J.F. et al. (2006b). The effect of polyphenols in olive oil on heart disease risk factors -A randomized trial. Annals of Internal Medicine. 145(5): 333-341.
  11. Demonty, I., Ras, R.T., van der Knaap, H.C.M., Duchateau, G.S.M.J., Meijer, L. et al. (2008). Continuous dose-response relationship of the LDL-cholesterol lowering effect of phytosterol intake. The Journal of Nutrition. 139 271-284.
  12. Earl, S., Cole, Z.A., Holroyd, C., Cooper, C. & Harvey, N.C. (2010). Dietary management of osteoporosis throughout the life course. Proceedings of the Nutrition Society. 69(01): 25-33.
  13. EC. 2006. Regulation (EC) No 1924/2006 on nutrition and health claims made on foods. EFSA. (2005). Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to an application concerning the use of betaine as a novel food in the EU. The EFSA Journal. 191 1-17. (doi:10.2903/j.efsa.2005.191) · DOI
  14. EFSA. (2008). The setting of nutrient profiles for foods bearing nutrition and health claims pursuant to Article 4 of the Regulation (EC) No 1924/2006 -Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. The EFSA Journal. 191 1-17. (doi:10.2903/j.efsa.2005.191) · DOI
  15. EFSA. (2009a). Bimuno TM and help to maintain a healthy gastro-intestinal function - Scientific substantiation of a health claim related to BimunoTM and help to maintain a healthy gastro-intestinal function pursuant to Article 13(5) of Regulation (EC) No 1924/2006. The EFSA Journal. 1107 1-10. (doi:10.2903/j.efsa.2009.1107) · DOI
  16. EFSA. (2009b). Opinion on the substantiation of health claims related to alpha linolenic acid and maintenance of normal blood cholesterol concentrations (ID 493) and maintenance of normal blood pressure (ID 625) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1252. (doi:10.2903/j.efsa.2009.1252) · DOI
  17. EFSA. (2009c). Scientific Opinion on substantiation of health claims related to thiamine and energy-yielding metabolism (ID 21, 24, 28), cardiac function (ID 20), function of the nervous system (ID 22, 27), maintenance of bone (ID 25), maintenance of teeth (ID 25), maintenance of hair (ID 25), maintenance of nails (ID 25), maintenance of skin (ID 25) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1222. (doi:10.2903/j.efsa.2009.1222) · DOI
  18. EFSA. (2009d). Scientific Opinion on the substantiation of health claims related to beta glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1524. (doi:10.2903/j.efsa.2009.1254) · DOI
  19. EFSA. (2009e). Scientific Opinion on the substantiation of health claims related to biotin and energy-yielding metabolism (ID 114, 117), macronutrient metabolism (ID 113, 114, 117), maintenance of skin and mucous membranes (ID 115), maintenance of hair (ID 118, 2876) and function of the nervous system (ID 116) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1209. (doi:10.2903/j.efsa.2009.1209) · DOI
  20. EFSA. (2009f). Scientific Opinion on the substantiation of health claims related to calcium and maintenance of bones and teeth (ID 224, 230, 231, 354, 3099), muscle function and neurotransmission (ID 226, 227, 230, 235), blood coagulation (ID 230, 236), energy-yielding metabolism (ID 234), function of digestive enzymes (ID 355), and maintenance of normal blood pressure (ID 225, 385, 1419) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1210. (doi:10.2903/j.efsa.2009.1210) · DOI
  21. EFSA. (2009g). Scientific Opinion on the substantiation of health claims related to calcium and vitamin D and maintenance of bone (ID 350) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1272. (doi:10.2903/j.efsa.2009.1272) · DOI
  22. EFSA. (2009h). Scientific Opinion on the substantiation of health claims related to copper and protection of DNA, proteins and lipids from oxidative damage (ID 263, 1726), function of the immune system (ID 264), maintenance of connective tissues (ID 265, 271, 1722), energy-yielding metabolism (ID 266), function of the nervous system (ID 267), maintenance of skin and hair pigmentation (ID 268, 1724), iron transport (ID 269, 270, 1727), cholesterol metabolism (ID 369), and glucose metabolism (ID 369) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1211. (doi:10.2903/j.efsa.2009.1211) · DOI
  23. EFSA. (2009i). Scientific Opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDL-cholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentrations of triglycerides (ID 517), maintenance of normal LDL- cholesterol concentrations (ID 528, 698) and maintenance of joints (ID 503, 505, 507, 511, 518, 524, 526, 535, 537) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1263. (doi:10.2903/j.efsa.2009.1263) · DOI
  24. EFSA. (2009j). Scientific Opinion on the substantiation of health claims related to fluoride and maintenance of tooth mineralisation (ID 275, 276) and maintenance of bone (ID 371) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1212. (doi:10.2903/j.efsa.2009.1212) · DOI
  25. EFSA. (2009k). Scientific Opinion on the substantiation of health claims related to folate and blood formation (ID 79), homocysteine metabolism (ID 80), energy-yielding metabolism (ID 90), function of the immune system (ID 91), function of blood vessels (ID 94, 175, 192), cell division (ID 193), and maternal tissue growth during pregnancy (ID 2882) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1213. (doi:10.2903/j.efsa.2009.1213 ) · DOI
  26. EFSA. (2009l). Scientific Opinion on the substantiation of health claims related to glucomannan and maintenance of normal blood cholesterol concentrations (ID 836, 1560) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1258. (doi:10.2903/j.efsa.2009.1258) · DOI
  27. EFSA. (2009m). Scientific Opinion on the substantiation of health claims related to iodine and thyroid function and production of thyroid hormones (ID 274), energy- yielding metabolism (ID 274), maintenance of vision (ID 356), maintenance of hair (ID 370), maintenance of nails (ID 370), and maintenance of skin (ID 370) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1214. (doi:10.2903/j.efsa.2009.1214) · DOI
  28. EFSA. (2009n). Scientific Opinion on the substantiation of health claims related to iron and formation of red blood cells and haemoglobin (ID 249, ID 1589), oxygen transport (ID 250, ID 254, ID 256), energy-yielding metabolism (ID 251, ID 1589), function of the immune system (ID 252, ID 259), cognitive function (ID 253) and cell division (ID 368) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1215. (doi:10.2903/j.efsa.2009.1215) · DOI
  29. EFSA. (2009o). Scientific Opinion on the substantiation of health claims related to lactase enzyme and breaking down lactose (ID 1697, 1818) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1236. (doi:10.2903/j.efsa.2009.1236) · DOI
  30. EFSA. (2009p). Scientific Opinion on the substantiation of health claims related to linoleic acid and maintenance of normal blood cholesterol concentrations (ID 489) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1276. (doi:10.2903/j.efsa.2009.1276) · DOI
  31. EFSA. (2009q). Scientific Opinion on the substantiation of health claims related to magnesium and electrolyte balance (ID 238), energy-yielding metabolism (ID 240, 247, 248), neurotransmission and muscle contraction including heart muscle (ID 241, 242), cell division (ID 365), maintenance of bone (ID 239), maintenance of teeth (ID 239), blood coagulation (ID 357) and protein synthesis (ID 364) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1216. (doi:10.2903/j.efsa.2009.1216) · DOI
  32. EFSA. (2009r). Scientific Opinion on the substantiation of health claims related to manganese and protection of DNA, proteins and lipids from oxidative damage (ID 309), maintenance of bone (ID 310), energy-yielding metabolism (ID 311), and cognitive function (ID 340) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1217. (doi:10.2903/j.efsa.2009.1217) · DOI
  33. EFSA. (2009s). Scientific Opinion on the substantiation of health claims related to niacin and energy-yielding metabolism (ID 43, 49, 54), function of the nervous system (ID 44, 53), maintenance of the skin and mucous membranes (ID 45, 48, 50, 52), maintenance of normal LDL-cholesterol, HDL cholesterol and triglyceride concentrations (ID 46), maintenance of bone (ID 50), maintenance of teeth (ID 50), maintenance of hair (ID 50, 2875) and maintenance of nails (ID 50, 2875) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1224. (doi:10.2903/j.efsa.2009.1224) · DOI
  34. EFSA. (2009t). Scientific Opinion on the substantiation of health claims related to pantothenic acid and energy-yielding metabolism (ID 56, 59, 60, 64, 171, 172, 208), mental performance (ID 57), maintenance of bone (ID 61), maintenance of teeth (ID 61), maintenance of hair (ID 61), maintenance of skin (ID 61), maintenance of nails (ID 61) and synthesis and metabolism of steroid hormones, vitamin D and some neurotransmitters (ID 181) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1218. (doi:10.2903/j.efsa.2009.1218) · DOI
  35. EFSA. (2009u). Scientific Opinion on the substantiation of health claims related to phosphorus and function of cell membranes (ID 328), energy-yielding metabolism (ID 329, 373) and maintenance of bone and teeth (ID 324, 327) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1219. (doi:10.2903/j.efsa.2009.1219) · DOI
  36. EFSA. (2009v). Scientific Opinion on the substantiation of health claims related to selenium and protection of DNA, proteins and lipids from oxidative damage (ID 277, 283, 286, 1289, 1290, 1291, 1293, 1751), function of the immune system (ID 278), thyroid function (ID 279, 282, 286, 1289, 1290, 1291, 1293), function of the heart and blood vessels (ID 280), prostate function (ID 284), cognitive function (ID 285) and spermatogenesis (ID 396) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1220. (doi:10.2903/j.efsa.2009.1220) · DOI
  37. EFSA. (2009w). Scientific Opinion on the substantiation of health claims related to sugar free chewing gum and dental and oral health, including gum and tooth protection and strength (ID 1149), plaque acid neutralisation (ID 1150), maintenance of tooth mineralisation (ID 1151), reduction of oral dryness (ID 1240), and maintenance of the normal body weight (ID 1152) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1271. (doi:10.2903/j.efsa.2009.1271) · DOI
  38. EFSA. (2009x). Scientific Opinion on the substantiation of health claims related to vitamin A and cell differentiation (ID 14), function of the immune system (ID 14), maintenance of skin and mucous membranes (ID 15, 17), maintenance of vision (ID 16), maintenance of bone (ID 13, 17), maintenance of teeth (ID 13, 17), maintenance of hair (ID 17), maintenance of nails (ID 17), metabolism of iron (ID 206), and protection of DNA, proteins and lipids from oxidative damage (ID 209) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1221. (doi:10.2903/j.efsa.2009.1221) · DOI
  39. EFSA. (2009y). Scientific Opinion on the substantiation of health claims related to vitamin B12 and red blood cell formation (ID 92, 101), cell division (ID 93), energy-yielding metabolism (ID 99, 190) and function of the immune system (ID 107) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1223. (doi:10.2903/j.efsa.2009.1223 ) · DOI
  40. EFSA. (2009z). Scientific Opinion on the substantiation of health claims related to vitamin B6 and protein and glycogen metabolism (ID 65, 70, 71), function of the nervous system (ID 66), red blood cell formation (ID 67, 72, 186), function of the immune system (ID 68), regulation of hormonal activity (ID 69) and mental performance (ID 185) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1225. (doi:10.2903/j.efsa.2009.1225) · DOI
  41. EFSA. (2009{). Scientific Opinion on the substantiation of health claims related to vitamin C and protection of DNA, proteins and lipids from oxidative damage (ID 129, 138, 143, 148), antioxidant function of lutein (ID 146), maintenance of vision (ID 141, 142), collagen formation (ID 130, 131, 136, 137, 149), function of the nervous system (ID 133), function of the immune system (ID 134), function of the immune system during and after extreme physical exercise (ID 144), non-haem iron absorption (ID 132, 147), energy-yielding metabolism (ID 135), and relief in case of irritation in the upper respiratory tract (ID 1714, 1715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1226. (doi:10.2903/j.efsa.2009.1226) · DOI
  42. EFSA. (2009|). Scientific Opinion on the substantiation of health claims related to vitamin D and maintenance of bone and teeth (ID 150, 151, 158), absorption and utilisation of calcium and phosphorus and maintenance of normal blood calcium concentrations (ID 152, 157), cell division (ID 153), and thyroid function (ID 156) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1227. (doi:10.2903/j.efsa.2009.1227) · DOI
  43. EFSA. (2009}). Scientific Opinion on the substantiation of health claims related to vitamin K and maintenance of bone (ID 123, 127, 128, and 2879), blood coagulation (ID 124 and 126), and function of the heart and blood vessels (ID 124, 125 and 2880) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1228. (doi:10.2903/j.efsa.2009.1228) · DOI
  44. EFSA. (2009~). Scientific Opinion on the substantiation of health claims related to zinc and function of the immune system (ID 291, 1757), DNA synthesis and cell division (ID 292, 1759), protection of DNA, proteins and lipids from oxidative damage (ID 294, 1758), maintenance of bone (ID 295, 1756), cognitive function (ID 296), fertility and reproduction (ID 297, 300), reproductive development (ID 298), muscle function (ID 299), metabolism of fatty acids (ID 302), maintenance of joints (ID 305), function of the heart and blood vessels (ID 306), prostate function (ID 307), thyroid function (ID 308), acid-base metabolism (ID 360), vitamin A metabolism (ID 361) and maintenance of vision (ID 361) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 7(9): 1229. (doi:10.2903/j.efsa.2009.1229) · DOI
  45. EFSA. (2009 ). Water-soluble tomato concentrate (WSTC I and II) and platelet aggregation. The EFSA Journal. 1101 1-15. (doi:10.2903/j.efsa.2009.1101 ) · DOI
  46. EFSA. (2010a). Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre. EFSA Journal. 8(3): 1462. (doi:10.2903/j.efsa.2010.1462) · DOI
  47. EFSA. (2010b). Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal. 8(3): 1461. (doi:10.2903/j.efsa.2010.1461) · DOI
  48. EFSA. (2010c). Scientific Opinion on the substantiation of a health claim related to ethanol- water extract of Caralluma fimbriata (Slimaluma®) and helps to reduce waist circumference pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal. 8(5): 1602. (doi:10.2903/j.efsa.2010.1602) · DOI
  49. EFSA. (2010d). Scientific Opinion on the substantiation of health claims related to biotin and maintenance of normal skin and mucous membranes (ID 121), maintenance of normal hair (ID 121), maintenance of normal bone (ID 121), maintenance of normal teeth (ID 121), maintenance of normal nails (ID 121, 2877), reduction of tiredness and fatigue (ID 119), contribution to normal psychological functions (ID 120) and contribution to normal macronutrient metabolism (ID 4661) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1728. (doi:10.2903/j.efsa.2010.1728) · DOI
  50. EFSA. (2010e). Scientific Opinion on the substantiation of health claims related to calcium and maintenance of normal bone and teeth (ID 2731, 3155, 4311, 4312, 4703), maintenance of normal hair and nails (ID 399, 3155), maintenance of normal blood LDL-cholesterol concentrations (ID 349, 1893), maintenance of normal blood HDL- cholesterol concentrations (ID 349, 1893), reduction in the severity of symptoms related to the premenstrual syndrome (ID 348, 1892), "cell membrane permeability" (ID 363), reduction of tiredness and fatigue (ID 232), contribution to normal psychological functions (ID 233), contribution to the maintenance or achievement of a normal body weight (ID 228, 229) and regulation of normal cell division and differentiation (ID 237) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1725. (doi:10.2903/j.efsa.2010.1725) · DOI
  51. EFSA. (2010f). Scientific Opinion on the substantiation of health claims related to chromium and contribution to normal macronutrient metabolism (ID 260, 401, 4665, 4666, 4667), maintenance of normal blood glucose concentrations (ID 262, 4667), contribution to the maintenance or achievement of a normal body weight (ID 339, 4665, 4666), and reduction of tiredness and fatigue (ID 261) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1732. (doi:10.2903/j.efsa.2010.1732) · DOI
  52. EFSA. (2010g). Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1734. (doi:10.2903/j.efsa.2010.1734) · DOI
  53. EFSA. (2010h). Scientific Opinion on the substantiation of health claims related to dried plums of 'prune' cultivars (Prunus domestica L.) and maintenance of normal bowel function (ID 1164) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(2): 1486. (doi:10.2903/j.efsa.2010.1486) · DOI
  54. EFSA. (2010j). Scientific Opinion on the substantiation of health claims related to folate and contribution to normal psychological functions (ID 81, 85, 86, 88), maintenance of normal vision (ID 83, 87), reduction of tiredness and fatigue (ID 84), cell division (ID 195, 2881) and contribution to normal amino acid synthesis (ID 195, 2881) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1760. (doi:10.2903/j.efsa.2010.1760) · DOI
  55. EFSA. (2010k). Scientific Opinion on the substantiation of health claims related to guar gum and maintenance of normal blood glucose concentrations (ID 794), increase in satiety (ID 795) and maintenance of normal blood cholesterol concentrations (ID 808) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(2): 1464. (doi:10.2903/j.efsa.2010.1464) · DOI
  56. EFSA. (2010l). Scientific Opinion on the substantiation of health claims related to hydroxypropyl methylcellulose (HPMC) and maintenance of normal bowel function (ID 812), reduction of post-prandial glycaemic responses (ID 814), maintenance of normal blood cholesterol concentrations (ID 815) and increase in satiety leading to a reduction in energy intake (ID 2933) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1739. (doi:10.2903/j.efsa.2010.1739) · DOI
  57. EFSA. (2010m). Scientific Opinion on the substantiation of health claims related to iodine and contribution to normal cognitive and neurological function (ID 273), contribution to normal energy-yielding metabolism (ID 402), and contribution to normal thyroid function and production of thyroid hormones (ID 1237) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1800. (doi:10.2903/j.efsa.2010.1800) · DOI
  58. EFSA. (2010n). Scientific Opinion on the substantiation of health claims related to iron and formation of red blood cells and haemoglobin (ID 374, 2889), oxygen transport (ID 255), contribution to normal energy-yielding metabolism (ID 255), reduction of tiredness and fatigue (ID 255, 374, 2889), biotransformation of xenobiotic substances (ID 258), and "activity of heart, liver and muscles" (ID 397) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1740.
  59. doi:10.2903/j.efsa.2010.1740) · DOI
  60. EFSA. (2010o). Scientific Opinion on the substantiation of health claims related to konjac mannan (glucomannan) and reduction of body weight (ID 854, 1556, 3725), reduction of post-prandial glycaemic responses (ID 1559), maintenance of normal blood glucose concentrations (ID 835, 3724), maintenance of normal (fasting) blood concentrations of triglycerides (ID 3217), maintenance of normal blood cholesterol concentrations (ID 3100, 3217), maintenance of normal bowel function (ID 834, 1557, 3901) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1558) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1798. (doi:10.2903/j.efsa.2010.1798) · DOI
  61. EFSA. (2010p). Scientific Opinion on the substantiation of health claims related to lactulose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 806) and reduction in intestinal transit time (ID 807) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1806. (doi:10.2903/j.efsa.2010.1806) · DOI
  62. EFSA. (2010q). Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1763. (doi:10.2903/j.efsa.2010.1763) · DOI
  63. EFSA. (2010r). Scientific Opinion on the substantiation of health claims related to magnesium and "hormonal health" (ID 243), reduction of tiredness and fatigue (ID 244), contribution to normal psychological functions (ID 245, 246), maintenance of normal blood glucose concentrations (ID 342), maintenance of normal blood pressure (ID 344, 366, 379), protection of DNA, proteins and lipids from oxidative damage (ID 351), maintenance of the normal function of the immune system (ID 352), maintenance of normal blood pressure during pregnancy (ID 367), resistance to mental stress (ID 375, 381), reduction of gastric acid levels (ID 376), maintenance of normal fat metabolism (ID 378) and maintenance of normal muscle contraction (ID 380, ID 3083) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1807. (doi:10.2903/j.efsa.2010.1807) · DOI
  64. EFSA. (2010s). Scientific Opinion on the substantiation of health claims related to manganese and reduction of tiredness and fatigue (ID 312), contribution to normal formation of connective tissue (ID 404) and contribution to normal energy yielding metabolism (ID 405) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1808. (doi:10.2903/j.efsa.2010.1808) · DOI
  65. EFSA. (2010t). Scientific Opinion on the substantiation of health claims related to meal replacements for weight control (as defined in Directive 96/8/EC on energy restricted diets for weight loss) and reduction in body weight (ID 1417), and maintenance of body weight after weight loss (ID 1418) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(2): 1466. (doi:10.2903/j.efsa.2010.1466) · DOI
  66. EFSA. (2010u). Scientific Opinion on the substantiation of health claims related to melatonin and alleviation of subjective feelings of jet lag (ID 1953), and reduction of sleep onset latency, and improvement of sleep quality (ID 1953) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(2): 1467. (doi:10.2903/j.efsa.2010.1467) · DOI
  67. EFSA. (2010v). Scientific Opinion on the substantiation of health claims related to molybdenum and contribution to normal amino acid metabolism (ID 313) and protection of DNA, proteins and lipids from oxidative damage (ID 341) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1745. (doi:10.2903/j.efsa.2010.1745) · DOI
  68. EFSA. (2010w). Scientific Opinion on the substantiation of health claims related to niacin and reduction of tiredness and fatigue (ID 47), contribution to normal energy- yielding metabolism (ID 51), contribution to normal psychological functions (ID 55), maintenance of normal blood flow (ID 211), and maintenance of normal skin and mucous membranes (ID 4700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1757. (doi:10.2903/j.efsa.2010.1757) · DOI
  69. EFSA. (2010x). Scientific Opinion on the substantiation of health claims related to pantothenic acid and mental performance (ID 58), reduction of tiredness and fatigue (ID 63), adrenal function (ID 204) and maintenance of normal skin (ID 2878) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1758. (doi:10.2903/j.efsa.2010.1758) · DOI
  70. EFSA. (2010y). Scientific Opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses (ID 786), maintenance of normal blood cholesterol concentrations (ID 818) and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1747. (doi:10.2903/j.efsa.2010.1747) · DOI
  71. EFSA. (2010z). Scientific Opinion on the substantiation of health claims related to plant sterols and plant stanols and maintenance of normal blood cholesterol concentrations (ID 549, 550, 567, 713, 1234, 1235, 1466, 1634, 1984, 2909, 3140), and maintenance of normal prostate size and normal urination (ID 714, 1467, 1635) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1813. (doi:10.2903/j.efsa.2010.1813) · DOI
  72. EFSA. (2010{). Scientific Opinion on the substantiation of health claims related to potassium and maintenance of normal muscular and neurological function (ID 320, 386) and maintenance of normal blood pressure (ID 321) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1469. (doi:10.2903/j.efsa.2010.1469) · DOI
  73. EFSA. (2010|). Scientific Opinion on the substantiation of health claims related to protein and increase in satiety leading to a reduction in energy intake (ID 414, 616, 730), contribution to the maintenance or achievement of a normal body weight (ID 414, 616, 730), maintenance of normal bone (ID 416) and growth or maintenance of muscle mass (ID 415, 417, 593, 594, 595, 715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1811. (doi:10.2903/j.efsa.2010.1811) · DOI
  74. EFSA. (2010}). Scientific Opinion on the substantiation of health claims related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism (ID 29, 35, 36, 42), contribution to normal metabolism of iron (ID 30, 37), maintenance of normal skin and mucous membranes (ID 31, 33), contribution to normal psychological functions (ID 32), maintenance of normal bone (ID 33), maintenance of normal teeth (ID 33), maintenance of normal hair (ID 33), maintenance of normal nails (ID 33), maintenance of normal vision (ID 39), maintenance of normal red blood cells (ID 40), reduction of tiredness and fatigue (ID 41), protection of DNA, proteins and lipids from oxidative damage (ID 207), and maintenance of the normal function of the nervous system (ID 213) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1814. (doi:10.2903/j.efsa.2010.1814) · DOI
  75. EFSA. (2010~). Scientific Opinion on the substantiation of health claims related to selenium and maintenance of normal hair (ID 281), maintenance of normal nails (ID 281), protection against heavy metals (ID 383), maintenance of normal joints (ID 409), maintenance of normal thyroid function (ID 410, 1292), protection of DNA, proteins and lipids from oxidative damage (ID 410, 1292), and maintenance of the normal function of the immune system (ID 1750) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1727. (doi:10.2903/j.efsa.2010.1727) · DOI
  76. EFSA. (2010 ). Scientific Opinion on the substantiation of health claims related to thiamin and reduction of tiredness and fatigue (ID 23) and contribution to normal psychological functions (ID 205) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1755. (doi:10.2903/j.efsa.2010.1755 ) · DOI
  77. EFSA. (2010€). Scientific Opinion on the substantiation of health claims related to vitamin B12 and contribution to normal neurological and psychological functions (ID 95, 97, 98, 100, 102, 109), contribution to normal homocysteine metabolism (ID 96, 103, 106), maintenance of normal bone (ID 104), maintenance of normal teeth (ID 104), maintenance of normal hair (ID 104), maintenance of normal skin (ID 104), maintenance of normal nails (ID 104), reduction of tiredness and fatigue (ID 108), and cell division (ID 212) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1756. (doi:10.2903/j.efsa.2010.1756) · DOI
  78. EFSA. (2010 ). Scientific Opinion on the substantiation of health claims related to vitamin B6 and contribution to normal homocysteine metabolism (ID 73, 76, 199), maintenance of normal bone (ID 74), maintenance of normal teeth (ID 74), maintenance of normal hair (ID 74), maintenance of normal skin (ID 74), maintenance of normal nails (ID 74), contribution to normal energy-yielding metabolism (ID 75, 214), contribution to normal psychological functions (ID 77), reduction of tiredness and fatigue (ID 78), and contribution to normal cysteine synthesis (ID 4283) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1759. (doi:10.2903/j.efsa.2010.1759) · DOI
  79. EFSA. (2010‚). Scientific Opinion on the substantiation of health claims related to vitamin C and reduction of tiredness and fatigue (ID 139, 2622), contribution to normal psychological functions (ID 140), regeneration of the reduced form of vitamin E (ID 202), contribution to normal energy-yielding metabolism (ID 2334, 3196), maintenance of the normal function of the immune system (ID 4321) and protection of DNA, proteins and lipids from oxidative damage (ID 3331) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1815. (doi:10.2903/j.efsa.2010.1815 ) · DOI
  80. EFSA. (2010ƒ). Scientific Opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(2): 1468. (doi:10.2903/j.efsa.2010.1468 ) · DOI
  81. EFSA. (2010"). Scientific Opinion on the substantiation of health claims related to vitamin E and protection of DNA, proteins and lipids from oxidative damage (ID 160, 162, 1947), maintenance of the normal function of the immune system (ID 161, 163), maintenance of normal bone (ID 164), maintenance of normal teeth (ID 164), maintenance of normal hair (ID 164), maintenance of normal skin (ID 164), maintenance of normal nails (ID 164), maintenance of normal cardiac function (ID 166), maintenance of normal vision by protection of the lens of the eye (ID 167), contribution to normal cognitive function (ID 182, 183), regeneration of the reduced form of vitamin C (ID 203), maintenance of normal blood circulation (ID 216) and maintenance of normal a scalp (ID 2873) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1816. (doi:10.2903/j.efsa.2010.1816 ) · DOI
  82. EFSA. (2010…). Scientific Opinion on the substantiation of health claims related to wheat bran fibre and increase in faecal bulk (ID 3066), reduction in intestinal transit time (ID 828, 839, 3067, 4699) and contribution to the maintenance or achievement of a normal body weight (ID 829) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1817. (doi:10.2903/j.efsa.2010.1817) · DOI
  83. EFSA. (2010 †). Scientific Opinion on the substantiation of health claims related to zinc and maintenance of normal skin (ID 293), DNA synthesis and cell division (ID 293), contribution to normal protein synthesis (ID 293, 4293), maintenance of normal serum testosterone concentrations (ID 301), "normal growth" (ID 303), reduction of tiredness and fatigue (ID 304), contribution to normal carbohydrate metabolism (ID 382), maintenance of normal hair (ID 412), maintenance of normal nails (ID 412) and contribution to normal macronutrient metabolism (ID 2890) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 8(10): 1819. (doi:10.2903/j.efsa.2010.1819) · DOI
  84. EFSA. (2011a). General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims. EFSA Journal. 9(4): 2135. (doi:10.2903/j.efsa.2011.2135) · DOI
  85. EFSA. (2011c). Scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1). EFSA Journal. 9(5): 2170. (doi:10.2903/j.efsa.2011.2170 ) · DOI
  86. EFSA. (2011d). Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency (ID 1698, 1780, 4080) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2241. (doi:10.2903/j.efsa.2011.2241) · DOI
  87. EFSA. (2011e). Scientific Opinion on the substantiation of health claims related to arabinoxylan produced from wheat endosperm and reduction of post-prandial glycaemic responses (ID 830) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2205. (doi:10.2903/j.efsa.2011.2205) · DOI
  88. EFSA. (2011f). Scientific Opinion on the substantiation of health claims related to beta- glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and "digestive function" (ID 850) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2207. (doi:10.2903/j.efsa.2011.2207) · DOI
  89. EFSA. (2011g). Scientific Opinion on the substantiation of health claims related to betaine and contribution to normal homocysteine metabolism (ID 4325) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2052. (doi:10.2903/j.efsa.2011.2052) · DOI
  90. EFSA. (2011h). Scientific Opinion on the substantiation of health claims related to caffeine and increase in physical performance during short-term high-intensity exercise (ID 737, 1486, 1489), increase in endurance performance (ID 737, 1486), increase in endurance capacity (ID 1488) and reduction in the rated perceived exertion/effort during exercise (ID 1488, 1490) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2053. (doi:10.2903/j.efsa.2011.2053) · DOI
  91. EFSA. (2011i). Scientific Opinion on the substantiation of health claims related to caffeine and increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101, 1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2054. (doi:10.2903/j.efsa.2011.2054) · DOI
  92. EFSA. (2011j). Scientific Opinion on the substantiation of health claims related to carbohydrate-electrolyte solutions and reduction in rated perceived exertion/effort during exercise (ID 460, 466, 467, 468), enhancement of water absorption during exercise (ID 314, 315, 316, 317, 319, 322, 325, 332, 408, 465, 473, 1168, 1574, 1593, 1618, 4302, 4309), and maintenance of endurance performance (ID 466, 469) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2211. (doi:10.2903/j.efsa.2011.2211) · DOI
  93. EFSA. (2011k). Scientific Opinion on the substantiation of health claims related to chitosan and reduction in body weight (ID 679, 1499), maintenance of normal blood LDL- cholesterol concentrations (ID 4663), reduction of intestinal transit time (ID 4664) and reduction of inflammation (ID 1985) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2214. (doi:10.2903/j.efsa.2011.2214) · DOI
  94. EFSA. (2011l). Scientific Opinion on the substantiation of health claims related to choline and contribution to normal lipid metabolism (ID 3186), maintenance of normal liver function (ID 1501), contribution to normal homocysteine metabolism (ID 3090), maintenance of normal neurological function (ID 1502), contribution to normal cognitive function (ID 1502), and brain and neurological development (ID 1503) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2056. (doi:10.2903/j.efsa.2011.2056) · DOI
  95. EFSA. (2011m). Scientific Opinion on the substantiation of health claims related to creatine and increase in physical performance during short-term, high intensity, repeated exercise bouts (ID 739, 1520, 1521, 1522, 1523, 1525, 1526, 1531, 1532, 1533, 1534, 1922, 1923, 1924), increase in endurance capacity (ID 1527, 1535), and increase in endurance performance (ID 1521, 1963) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(7): 2303. (doi:10.2903/j.efsa.2011.2303) · DOI
  96. EFSA. (2011n). Scientific Opinion on the substantiation of health claims related to fats and "function of the cell membrane" (ID 622, 2900, 2911) and normal absorption of fat- soluble vitamins (ID 670, 2902) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2220. (doi:10.2903/j.efsa.2011.2220) · DOI
  97. EFSA. (2011o). Scientific Opinion on the substantiation of health claims related to foods with reduced amounts of saturated fatty acids (SFAs) and maintenance of normal blood LDL cholesterol concentrations (ID 620, 671, 4332) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2062. (doi:10.2903/j.efsa.2011.2062) · DOI
  98. EFSA. (2011p). Scientific Opinion on the substantiation of health claims related to foods with reduced amounts of sodium and maintenance of normal blood pressure (ID 336, 705, 1148, 1178, 1185, 1420) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2237. (doi:10.2903/j.efsa.2011.2237) · DOI
  99. EFSA. (2011q). Scientific Opinion on the substantiation of health claims related to foods with reduced lactose content and decreasing gastro-intestinal discomfort caused by lactose intake in lactose intolerant individuals (ID 646, 1224, 1238, 1339) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2236. (doi:10.2903/j.efsa.2011.2236) · DOI
  100. EFSA. (2011r). Scientific Opinion on the substantiation of health claims related to glycaemic carbohydrates and maintenance of normal brain function (ID 603, 653) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2226. (doi:10.2903/j.efsa.2011.2226) · DOI
  101. EFSA. (2011s). Scientific Opinion on the substantiation of health claims related to intense sweeteners and contribution to the maintenance or achievement of a normal body weight (ID 1136, 1444, 4299), reduction of post-prandial glycaemic responses (ID 4298), maintenance of normal blood glucose concentrations (ID 1221, 4298), and maintenance of tooth mineralisation by decreasing tooth demineralisation (ID 1134, 1167, 1283) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2229. (doi:10.2903/j.efsa.2011.2229) · DOI
  102. EFSA. (2011t). Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(7): 2304. (doi:10.2903/j.efsa.2011.2304) · DOI · Paper page
  103. EFSA. (2011u). Scientific Opinion on the substantiation of health claims related to oat and barley grain fibre and increase in faecal bulk (ID 819, 822) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2249. (doi:10.2903/j.efsa.2011.2249) · DOI
  104. EFSA. (2011v). Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), "anti- inflammatory properties" (ID 1882), "contributes to the upper respiratory tract health" (ID 3468), "can help to maintain a normal function of gastrointestinal tract" (3779), and "contributes to body defences against external agents" (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2033. (doi:10.2903/j.efsa.2011.2033) · DOI
  105. EFSA. (2011w). Scientific Opinion on the substantiation of health claims related to resistant starch and reduction of post-prandial glycaemic responses (ID 681), "digestive health benefits" (ID 682) and "favours a normal colon metabolism" (ID 783) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2024. (doi:10.2903/j.efsa.2011.2024) · DOI
  106. EFSA. (2011x). Scientific Opinion on the substantiation of health claims related to rye fibre and changes in bowel function (ID 825), reduction of post prandial glycaemic responses (ID 826) and maintenance of normal blood LDL-cholesterol concentrations (ID 827) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2258. (doi:10.2903/j.efsa.2011.2258) · DOI
  107. EFSA. (2011y). Scientific Opinion on the substantiation of health claims related to sodium and maintenance of normal muscle function (ID 359) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2260. (doi:10.2903/j.efsa.2011.2260) · DOI
  108. EFSA. (2011z). Scientific Opinion on the substantiation of health claims related to sugar-free chewing gum with carbamide and plaque acid neutralisation (ID 1153) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2071. (doi:10.2903/j.efsa.2011.2071 ) · DOI
  109. EFSA. (2011{). Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2069. (doi:10.2903/j.efsa.2011.2069) · DOI
  110. EFSA. (2011|). Scientific Opinion on the substantiation of health claims related to the sugar replacers xylitol, sorbitol, mannitol, maltitol, lactitol, isomalt, erythritol, D-tagatose, isomaltulose, sucralose and polydextrose and maintenance of tooth mineralisation by decreasing tooth demineralisation (ID 463, 464, 563, 618, 647, 1182, 1591, 2907, 2921, 4300), and reduction of post-prandial glycaemic responses (ID 617, 619, 669, 1590, 1762, 2903, 2908, 2920) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2076. (doi:10.2903/j.efsa.2011.2076) · DOI
  111. EFSA. (2011}). Scientific Opinion on the substantiation of health claims related to very low calorie diets (VLCDs) and reduction in body weight (ID 1410), reduction in the sense of hunger (ID 1411), reduction in body fat mass while maintaining lean body mass (ID 1412), reduction of post-prandial glycaemic responses (ID 1414), and maintenance of normal blood lipid profile (1421) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(6): 2271. (doi:10.2903/j.efsa.2011.2271) · DOI
  112. EFSA. (2011~). Scientific Opinion on the substantiation of health claims related to water and maintenance of normal physical and cognitive functions (ID 1102, 1209, 1294, 1331), maintenance of normal thermoregulation (ID 1208) and "basic requirement of all living things" (ID 1207) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 9(4): 2075. (doi:10.2903/j.efsa.2011.2075) · DOI
  113. Geissler, C. and Powers, H. Geissler, C. and Powers, H. Eds.(2005) Human Nutrition. Elsevier, Edinburgh.
  114. Gibson, G.R. & Roberfroid, M.B. (1995). Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics. The Journal of Nutrition. 125(6): 1401-1412.
  115. Grossklaus, R. (2009). Codex recommendations on the scientific basis of health claims. European Journal of Nutrition. 48 S15-S22.
  116. Hoefkens, C., Verbeke, W. & Van Camp, J. (2011). European consumers' perceived importance of qualifying and disqualifying nutrients in food choices. Food Quality and Preference. 22(6): 550-558.
  117. Ikeda, Y., Iki, M., Morita, A., Kajita, E., Kagamimori, S. et al. (2006). Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese population-based osteoporosis (JPOS) study. J. Nutr. 136(5): 1323-1328.
  118. Jadhav, S.J., Lutz, S.E., Ghorpade, V.M. & Salunkhe, D.K. (1998). Barley: Chemistry and value-added processing. Critical Reviews in Food Science and Nutrition. 38(2): 123-171.
  119. Katsuyama, H., Ideguchi, S., Fukunaga, M., Fukunaga, T., Saijoh, K. et al. (2004). Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women. Journal of Nutritional Science and Vitaminology. 50(2): 114-120.
  120. Krutulyte, R., Grunert, K.G., Scholderer, J., Lahteenmaki, L., Hagemann, K.S. et al. (2011). Perceived fit of different combinations of carriers and functional ingredients and its effect on purchase intention. Food Quality and Preference. 22(1): 11-16.
  121. Lalor, F., Kennedy, J., Flynn, M.A. & Wall, P.G. (2010). A study of nutrition and health claims? a snapshot of what's on the Irish market. Public Health Nutrition. 13(05): 704- 711.
  122. Ling, W.H. & Jones, P.J.H. (1995). Dietary phytosterols: A review of metabolism, benefits and side effects. Life Sciences. 57(3): 195-206.
  123. Palacios, C. (2006). The role of nutrients in bone health, from A to Z. Crit. Rev. Food Sci. Nutr. 46(8): 621-628.
  124. Pothoulaki, M. & Chryssochoidis, G. (2009). Health claims: Consumers' matters. Journal of Functional Foods. 1(2): 222-228.
  125. Pravst, I. (2010). The evaluation of health claims in Europe: What have we learned? AgroFOOD industry hi-tech. 21(4): 4-6.
  126. Pravst, I. (2011a). Health claims: Where are we now and where are we going? (editorial) Agro Food Industry Hi-Tech. 22(4): 2-3.
  127. Pravst, I. & Žmitek, K. (2011). The coenzyme Q10 content of food supplements. Journal fur Verbraucherschutz und Lebensmittelsicherheit-Journal of Consumer Protection and Food Safety. 6: 457-463.
  128. Pravst, I., Žmitek, K. & Žmitek, J. (2010). Coenzyme Q10 contents in foods and fortification strategies. Crit. Rev. Food Sci. Nutr. 50(4): 269-280.
  129. Sioen, I., Matthys, C., Huybrechts, I., Van Camp, J. & De Henauw, S. (2011). Consumption of plant sterols in Belgium: consumption patterns of plant sterol-enriched foods in Flanders, Belgium. British Journal of Nutrition. 105(06): 911-918.
  130. St Onge, M.P. & Jones, P.J.H. (2003). Phytosterols and human lipid metabolism: efficacy, safety, and novel foods. Lipids. 38(4): 367-375.
  131. Talati, R., Baker, W.L., Pabilonia, M.S., White, C.M. & Coleman, C.I. (2009). The Effects of Barley-Derived Soluble Fiber on Serum Lipids. Ann Fam Med. 7(2): 157-163.
  132. Turner, N.D. & Lupton, J.R. (2011). Dietary Fiber. Advances in Nutrition: An International Review Journal. 2(2): 151-152.
  133. Urala, N. & Lahteenmaki, L. (2004). Attitudes behind consumers' willingness to use functional foods. Food Quality and Preference. 15(7-8): 793-803.
  134. Verbeke, W. (2005). Consumer acceptance of functional foods: socio-demographic, cognitive and attitudinal determinants. Food Quality and Preference. 16(1): 45-57.
  135. Verbeke, W. (2006). Functional foods: Consumer willingness to compromise on taste for health? Food Quality and Preference. 17(1-2): 126-131.
  136. Verbeke, W. (2010). Consumer reactions to foods with nutrition and health claims. Agro Food Industry Hi-Tech. 21(6): 5-8.
  137. Verbeke, W., Scholderer, J. & Lahteenmaki, L. (2009). Consumer appeal of nutrition and health claims in three existing product concepts. Appetite. 52(3): 684-692.
  138. Vermeer, C., Shearer, M.J., Zittermann, A., Bolton-Smith, C., Szulc, P. et al. (2004). Beyond deficiency: Potential benefits of increased intakes of vitamin K for bone and vascular health. Eur. J. Nutr. 43(6): 325-335.
  139. WHO (2003). Recomendations for preventing cardiovascular diseases. In: WHO Technical Report Series. pp. 81-94. World Health Organization, Geneva.
  140. Wills, J.M., Schmidt, D.B., Pillo-Blocka, F. & Cairns, G. (2009). Exploring global consumer attitudes toward nutrition information on food labels. Nutrition Reviews. 67(5): S102-S106.
  141. Zeisel, S.H. & Caudill, M.A. (2010). Choline. Advances in Nutrition: An International Review Journal. 1(1): 46-48.

Cited by

Sorted by citations

Authors
Pravst, I.
Affiliations
Inštitut za Nutricionistiko (SI)
Corresponding author
Pravst, Igor
ORCID
Pravst, Igor
Venue
Scientific, Health and Social Aspects of the Food Industry
Publisher
InTech
Published
2012-02-01
DOI
10.5772/31057
OpenAlex
W1578610364
Cited by
42
References
9
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2019: 10 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 2 · 2014: 4
FWCI
4.48
Type
book chapter
Language
en
Open access
Licence
cc-by
Locations
  • InTech eBooks (publishedVersion, cc-by)
  • DiRROS repository (University of Maribor) (publishedVersion, cc-by)
  • BiblioBoard Library Catalog (Open Research Library) (submittedVersion, cc-by)
  • dCOBISS.SI Digital Repository (submittedVersion, cc-by)
  • Contact-less Assessment of In-vivo Body Signals Using Microwave Doppler Radar (InTech) (submittedVersion, cc-by-nc)
Funders
Javna Agencija za Raziskovalno Dejavnost RS (V7-1107)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Consumer Attitudes and Food Labeling
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Food and Agricultural Sciences
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
Keywords
functional foods, health claims, food law, dietary supplements, foods for special medical purposes, medicinal food

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review